U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541365) titled 'Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials' on April 06.
Brief Summary: Wearable sensors offer opportunities to improve the people's experiences with cancer treatment and to improve care delivery. This is a single-arm, prospective, unblinded pilot study designed to evaluate the feasibility and acceptability of wearable sensor-based monitoring and incorporating electronic patient-reported outcomes (ePROs) in Phase I oncology clinical trials. The study will enroll participants enrolled in early phase clinical trials at the Cleveland Clinic Novel Therapeutics Clinic and aims to establish...